Perioperative Levetiracetam for seizure prophylaxis in brain tumor patients. Prospective evaluation of side effects and efficacy
- Conditions
- Data on perioperative seizure prophylaxis in brain tumor patients as weilas on specific side effects is limited in scientific literature.Epileptic seizures during and after brain tumor surgery may lead tosevere complication as tor example intracranial hypertension, brainherniation and neurologie impairment.Aim of this study is the evaluation of efficacy and side effects ofLevetiracetam in perioperative seizure prophylaxis in patients sufferingtrom brain tumors.Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
- Registration Number
- EUCTR2015-003916-19-AT
- Lead Sponsor
- Karl Landsteiner Institut für klinische Neurologie und Neuropsycholigie
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
adult patients (age 18-90) planned to undergo brain surgery because of supratentorial brain tumor
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 50
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 50
Exclusion Criteria
Contraindication against Levetiracetam , preexisting anticonvulsive medication
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method